Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBSYS in ED Patients With Acute Pain
NCT02137525Phase 2Withdrawn
- Sponsor
- Insys Therapeutics
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in acute pain, sponsored by Insys Therapeutics. Status: withdrawn.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02137525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137525.